SUN.L • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold SUN.L in your mock portfolio yet.
The reported PE ratio of 0.00 and EPS of 0.00 imply that the market currently assigns no meaningful earnings to Surgical Innovations Group, suggesting either breakeven or loss-making operations. In the absence of positive earnings, profitability and return-based ratios are weak or non-existent, which undermines the investment case until there is clearer evidence of sustainable profit generation.
The stock trades at $0.45, flat over the last month, but below its 200-day moving average of $0.62, signaling a longer-term downtrend or underperformance. An extremely low RSI reading of 0.01 formally indicates extreme oversold conditions, but in micro-cap names this can also reflect persistent selling pressure and low liquidity rather than an imminent rebound.
Alternative data points show limited digital traction and muted corporate activity. Web traffic is very low, job postings are at zero, and social media followings are small and slightly declining, all of which point to a lack of visible growth momentum or expanding commercial footprint.
Taken together, the lack of earnings, depressed price relative to the 200-day moving average, and weak alternative data signals point to a bearish outlook for Surgical Innovations Group at this time. While the extremely low RSI could eventually set the stage for a technical bounce, the absence of clear fundamental or growth catalysts makes the risk/reward profile unfavorable until there is evidence of operational improvement.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: